Cardinal Health Canada To Open New Distribution Center In Greater Toronto Area

Shares of Cardinal Health, Inc. were gaining more than 7 percent in the pre-market activity on the NYSE after the healthcare company on Wednesday raised its fiscal 2024 adjusted earnings forecast above the market after reporting a profit in its fourth quarter, compared to prior year's loss. The improved results reflected strong revenues from both segments.

Cardinal Health, Inc. is recalling certain Leader branded eye drops supplied by Velocity Pharma, LLC citing potential risk of eye infections, according to the US. Food and Drug Administration. The recall was initiated after the FDA informed the Dublin, Ohio-based company that investigators found insanitary conditions in the manufacturing facility and positive bacterial test results...

Cardinal Health, Inc. (CAH) announced Monday it has signed a definitive agreement to merge its Outcomes business to Transaction Data Systems (TDS), a portfolio company of BlackRock Long Term Private Capital and GTCR, in exchange for a minority stake in the combined entity.

Cardinal Health (CAH) and its board of directors announced Monday that Aaron Alt will become the company's new chief financial officer (CFO). Alt will succeed interim CFO, Trish English and will report to CEO Jason Hollar, as a member of the company's Executive Committee effective February 10.

While reporting financial results for the first quarter on Friday, healthcare services company Cardinal Health, Inc. (CAH) reaffirmed its adjusted earnings guidance for the full-year 2023 in the range of $5.05 to $5.40 per share.

Healthcare services company Cardinal Health (CAH) announced Thursday that its Board of Directors has elected Jason Hollar as the company's next Chief Executive Officer, effective September 1, 2022. Hollar will also join the Board of Directors effective August 11, 2022. Hollar will succeed current Chief Executive Officer Mike Kaufmann.

The euro firmed against its major counterparts in the New York session on Friday, as risk sentiment improved after U.S. President Donald Trump delayed decision on joining the Israel-Iran conflict.

Gold climbed higher on Thursday amid renewed threats of a tariff war, simmering US-Iran geopolitical tensions, and a softer U.S. jobs data. Front Month Comex Gold for June delivery gained $59.60 (or 1.79%) to $3380.90 per troy ounce. Front Month Comex Silver for June delivery gained 4.70 cents (or 0.13%) to $36.213 today. In a significant development, U.S. President Donald Trump said that, in the coming weeks, he is going to send letters to nations trading with US, setting unilateral tariffs even ahead of the July 9 deadline he had already set for negotiations. Adding to geopolitical tension, the U.S. has begun evacuating non-essential staff from its Baghdad embassy. This move comes after Trump's statement where he said that he felt less confident of a US-Iran nuclear deal. He however had added that US would not allow Iran to have nuclear weapons. Iranian defense minister responded to this saying Iran would attack U.S. bases if there is a conflict. According to data released by the U.S. Commerce Department, producer prices have edged up 0.1 percent for May 2025, compared to forecasts of a 0.2 percent increase. Also, the US Labor Department revealed that the initial jobless claims in the U.S. held steady at 2,48,000 for the first week of June contrary to market expectations of a drop to 2,40,000. Continuing jobless claims jumped by 54,000 to 19,56,000 in the week ending May 31. All these data indicated a soft U.S. labor market amid ongoing economic uncertainty. The U.S. dollar fell to a more than three-year low. In light of these developments, market expectations of a rate cut in September by the U.S. Federal Reserve has now increased.